Literature DB >> 19751400

T lymphocyte responses to heterologous secondary dengue virus infections.

Alan L Rothman1.   

Abstract

The available evidence suggests that plasma leakage in dengue hemorrhagic fever is caused by the action of circulating mediators on the vascular endothelium, and that the host immune response is a critical determinant of this response. We have been exploring the role of dengue virus-specific T lymphocytes in the immunopathogenesis of plasma leakage. Memory dengue virus-specific T cells induced during a primary dengue virus infection are reactivated by the heterologous viral serotype during a secondary infection to expand to high levels and produce a skewed cytokine profile. Investigations are underway to identify the immunologic profiles associated with increased or decreased risk for severe disease.

Entities:  

Mesh:

Year:  2009        PMID: 19751400     DOI: 10.1111/j.1749-6632.2009.05055.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  22 in total

1.  Bi-specific MHC heterodimers for characterization of cross-reactive T cells.

Authors:  Zu T Shen; Michael A Brehm; Keith A Daniels; Alexander B Sigalov; Liisa K Selin; Raymond M Welsh; Lawrence J Stern
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

2.  NIAID workshop on Flavivirus immunity.

Authors:  Alison D Augustine; M Cristina Cassetti; Francis A Ennis; Eva Harris; William H Hildebrand; Patricia M Repik
Journal:  Viral Immunol       Date:  2010-06       Impact factor: 2.257

Review 3.  Immune-mediated cytokine storm and its role in severe dengue.

Authors:  Anon Srikiatkhachorn; Anuja Mathew; Alan L Rothman
Journal:  Semin Immunopathol       Date:  2017-04-11       Impact factor: 9.623

4.  The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection.

Authors:  Hui-Mei Hu; Hsin-Wei Chen; Yu-Ju Hsiao; Szu-Hsien Wu; Han-Hsuan Chung; Chun-Hsiang Hsieh; Pele Chong; Chih-Hsiang Leng; Chien-Hsiung Pan
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

5.  Disparate epitopes mediating protective heterologous immunity to unrelated viruses share peptide-MHC structural features recognized by cross-reactive T cells.

Authors:  Zu T Shen; Tina T Nguyen; Keith A Daniels; Raymond M Welsh; Lawrence J Stern
Journal:  J Immunol       Date:  2013-10-14       Impact factor: 5.422

6.  Variation in inflammatory/regulatory cytokines in secondary, tertiary, and quaternary challenges with dengue virus.

Authors:  Beatriz Sierra; Ana B Pérez; Mayling Alvarez; Gissel García; Katrin Vogt; Eglys Aguirre; Kathrin Schmolke; Hans-Dieter Volk; María G Guzmán
Journal:  Am J Trop Med Hyg       Date:  2012-07-16       Impact factor: 2.345

Review 7.  Dengue virus life cycle: viral and host factors modulating infectivity.

Authors:  Izabela A Rodenhuis-Zybert; Jan Wilschut; Jolanda M Smit
Journal:  Cell Mol Life Sci       Date:  2010-04-06       Impact factor: 9.261

Review 8.  Dengue vaccines: recent developments, ongoing challenges and current candidates.

Authors:  Monica A McArthur; Marcelo B Sztein; Robert Edelman
Journal:  Expert Rev Vaccines       Date:  2013-08       Impact factor: 5.217

Review 9.  Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus.

Authors:  Carlo Amorin Daep; Jorge L Muñoz-Jordán; Eliseo Alberto Eugenin
Journal:  J Neurovirol       Date:  2014-10-07       Impact factor: 2.643

10.  Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study.

Authors:  D Priyadarshini; Rajesh R Gadia; Anuradha Tripathy; K R Gurukumar; Asha Bhagat; Sampada Patwardhan; Nitin Mokashi; Dhananjay Vaidya; Paresh S Shah; D Cecilia
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.